Clinical Trial Update: Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating safety, tolerability, and preliminary efficacy of B244 in healthy volunteers and individuals with seasonal allergic rhinitis due t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinitis Due to Grass Pollen

Drugs mentioned

• B244

Snippet

Sponsor: AOBiome LLC | Conditions: Allergic Rhinitis, Allergic Rhinitis Due to Grass Pollen | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-11-25